Wanbang Pharmaceutical Holding Group (002082.SZ): Approved Supplemental Drug Application for Chlorpromazine Hydrochloride Tablets

17/11/2024

GMT Eight

Wanbangde Pharmaceutical Holding Group (002082.SZ) announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Holding Group Pharmaceutical Group Co., Ltd., recently received the "Drug Supplement Application Approval Notification" issued by the National Medical Products Administration for Chlorpromazine Hydrochloride Tablets. Chlorpromazine Hydrochloride Tablets are a phenothiazine antipsychotic drug that can be used to treat schizophrenia, mania, nausea, vomiting due to various reasons, and intractable hiccups.

Guangdong Zhongsheng Pharmaceutical (002317.SZ): The first participant has been enrolled in the Phase II clinical trial of Angladivir granules.

Beijing ZZNode Technologies (003007.SZ): Application for private placement has been accepted by the Shenzhen Stock Exchange.

Contact: contact@gmteight.com

Wanbang Pharmaceutical Holding Group (002082.SZ): Approved Supplemental Drug Application for Chlorpromazine Hydrochloride Tablets

RECOMMEND

Shenwan Hongyuan Group: Short-term market momentum still exists but the phase of year-end validation is approaching, the market may face adjustment pressure.

SIMPLICITY HLDG(08367): Intended to re-approve the company name change.

China Baoli Tec (00164) has signed a memorandum of understanding with Pan-Asia Resources on the mining and production of coal mines to establish long-term strategic cooperation.